Angiotensin II in Septic Shock: Effects on Tissue Perfusion, Organ Function, and Mitochondrial Respiration in a Porcine Model of Fecal Peritonitis*

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Critical Care Medicine

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CCM.0000000000000397PMID 24797374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock

  2013cited by this paper
• Histologic Pathologies of the Myocardium in Septic Shock: A Prospective Observational Study

  2013cited by this paper
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  2013cited by this paper
• Increasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function

  2013influential reference
• Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.

  2012cited by this paper
• Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion

  2012influential reference
• Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis

  2012cited by this paper
• Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*

  2012cited by this paper
• Effects of catecholamines on hepatic and skeletal muscle mitochondrial respiration after prolonged exposure to faecal peritonitis in pigs

  2012cited by this paper
• Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis

  2010cited by this paper
• Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock.

  2010cited by this paper
• Acute renal failure is NOT an “acute renal success”—a clinical study on the renal oxygen supply/demand relationship in acute kidney injury

  2010cited by this paper
• ACE-inhibitor therapy and survival among patients with multiorgan dysfunction syndrome (MODS) of cardiac and non-cardiac origin.

  2010cited by this paper
• Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models*

  2009cited by this paper
• Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial

  2009cited by this paper
• Angiotensin II in experimental hyperdynamic sepsis

  2009influential reference
• Norepinephrine to increase blood pressure in endotoxaemic pigs is associated with improved hepatic mitochondrial respiration

  2008cited by this paper
• Vasopressin versus norepinephrine infusion in patients with septic shock.

  2008cited by this paper
• Glucose metabolism and catecholamines

  2007cited by this paper
• Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

  2007cited by this paper
• Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.

  2006cited by this paper
• Renal blood flow in experimental septic acute renal failure.

  2006cited by this paper
• The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia

  2005cited by this paper
• Acute renal failure and sepsis.

  2004cited by this paper
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

  2004cited by this paper
• Enalapril and losartan attenuate mitochondrial dysfunction in aged rats

  2003cited by this paper
• Heart rate variability – a therapeutic target?

  2002cited by this paper
• Downregulation of Angiotensin II Type 1 Receptors During Sepsis

  2001cited by this paper
• Physiological response to acute endotoxemia in swine: effect of genotype on energy metabolites and leptin.

  2000cited by this paper
• Angiotensin for septic shock unresponsive to noradrenaline

  2000cited by this paper
• Norepinephrine and N ω-Monomethyl-l-arginine in Porcine Septic Shock

  1999cited by this paper
• Norepinephrine and nomega-monomethyl-L-arginine in porcine septic shock: effects on hepatic O2 exchange and energy balance.

  1999cited by this paper
• Severe septic shock unresponsive to noradrenaline.

  1995cited by this paper
• Enalapril maleate affects 2‐oxoglutarate metabolism in mitochondria from the rat kidney cortex

  1994cited by this paper
• Catecholamines: important factors in the increase of oxidative phosphorylation coupling in rat-liver mitochondria during the early phase of burn injury.

  1993cited by this paper
• Dose-response study of the redistribution of intravascular volume by angiotensin II in man.

  1992cited by this paper
• Administration of angiotensin II in refractory septic shock.

  1991cited by this paper
• Renal sodium transport and oxygen consumption.

  1961cited by this paper

• MIDAS: rapid, multiplexed molecular profiling for integrated host–pathogen analysis

  2025cites this paper
• Renal perfusion pressure: role and implications in critical illness

  2025cites this paper
• Role of the renin-angiotensin-aldosterone system in sepsis and its therapeutic targets.

  2025cites this paper
• Rethinking the obesity paradox in sepsis: Metabolic pharmacotherapy explains survival benefits of obesity.

  2025cites this paper
• ANGIOTENSIN II IN THE TREATMENT OF DISTRIBUTIVE SHOCK: A SYSTEMATIC-REVIEW AND META-ANALYSIS

  2024cites this paper
• Impaired angiotensin II signaling in septic shock

  2024cites this paper
• A neutrophil elastase inhibitor, sivelestat, attenuates sepsis-induced acute kidney injury by inhibiting oxidative stress

  2024cites this paper
• Effect of Vasopressors and Vasodilators on Kidney Medulla Oxygenation

  2024cites this paper
• Exploring post-SEPSIS and post-COVID-19 syndromes: crossovers from pathophysiology to therapeutic approach

  2024cites this paper
• Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review

  2024cites this paper
• THE EFFECT OF CATECHOLAMINE VERSUS NONCATECHOLAMINE VASOPRESSORS ON RENAL FUNCTION AND RECOVERY IN VASODILATORY SHOCK: A SYSTEMATIC REVIEW OF PRECLINICAL AND CLINICAL STUDIES

  2024cites this paper
• Current perspectives in the management of sepsis and septic shock

  2024cites this paper
• Synthetic Angiotensin II ameliorates alterations of systemic hemodynamics, microcirculatory deterioration, and renal damage in septic rats.

  2024cites this paper
• Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis*

  2023cites this paper
• Association between Premorbid Renin-Angiotensin-Aldosterone System Blockade and the Risk of Acute Kidney Injury in Critically Ill Patients.

  2023cites this paper
• Sepsis modulates aortic AT1 and P2Y6 receptors to produce vascular hyporeactivity in mice

  2023cites this paper
• Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review

  2022cites this paper
• Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review

  2022cites this paper
• Autonomic and circulatory alterations persist despite adequate resuscitation in a 5-day sepsis swine experiment

  2022cites this paper
• Previous antithrombotic therapy does not have an impact on the in-hospital mortality of patients with upper gastrointestinal bleeding

  2022cites this paper
• Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock

  2022cites this paper
• Protective Effect of the Chinese Herb Draba Scabra on the Sepsis Myocarditis in Molecular Mechanism

  2022cites this paper
• Alternatives to norepinephrine in septic shock: Which agents and when?

  2022cites this paper
• Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

  2022cites this paper
• Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications.

  2021cites this paper
• Dysregulation of the renin-angiotensin system in septic shock: mechanistic insights and application of angiotensin II in clinical management.

  2021cites this paper
• Targeting Oxidative Stress in Septic Acute Kidney Injury: From Theory to Practice

  2021cites this paper
• Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review

  2021cites this paper
• Angiotensin II-mediated improvement of renal mitochondrial function via the AMPK/PGC-1α/NRF-2 pathway is superior to norepinephrine in a rat model of septic shock associated with acute renal injury

  2021cites this paper
• Prior Exposure to Angiotensin II Receptor Blockers in Patients With Septic Shock to Individualize Mean Arterial Pressure Target? A Post Hoc Analysis of the Sepsis and Mean Arterial Pressure (SEPSISPAM) Trial*

  2021influential citation
• Emerging benefits and drawbacks of α2‐adrenoceptor agonists in the management of sepsis and critical illness

  2021cites this paper
• Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia

  2020cites this paper
• Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis

  2020cites this paper
• Ramipril pretreatment worsened renal injury and survival despite a reduction in renal inflammation in experimentally induced sepsis in mice

  2020cites this paper
• Roles of angiotensin II as vasopressor in vasodilatory shock.

  2020cites this paper
• Defense mechanisms to increasing back pressure for hepatic oxygen transport and venous return in porcine fecal peritonitis.

  2020cites this paper
• The Surviving Sepsis Campaign: Basic/Translational Science Research Priorities*

  2020cites this paper
• Septic acute kidney injury: a review of basic research

  2020cites this paper
• Renin-Angiotensin-Aldosterone System Blockade Strategies and the Risk of Acute Kidney Injury in Septic and Critically Ill Patients

  2020cites this paper
• New drugs for acute kidney injury

  2020influential citation
• Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury.

  2019cites this paper
• The Systemic Alterations of Lipids, Alanine-Glucose Cycle and Inter-Organ Amino Acid Metabolism in Swine Model Confirms the Role of Liver in Early Phase of Septic Shock

  2019cites this paper
• Drugs in Development for Acute Kidney Injury

  2019cites this paper
• Local gastric RAAS inhibition improves gastric microvascular perfusion in dogs.

  2019cites this paper
• Angiotensin II in septic shock.

  2019cites this paper
• Novel Drugs for Acute Kidney Injury

  2019cites this paper
• Renal Medullary Hypoxia: A New Therapeutic Target for Septic Acute Kidney Injury?

  2019cites this paper
• Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis

  2019cites this paper
• Endocrine Effects of Simulated Complete and Partial Aortic Occlusion in a Swine Model of Hemorrhagic Shock.

  2018cites this paper
• Sepsis‐induced acute kidney injury: A disease of the microcirculation

  2018cites this paper
• Urinary Oxygenation as a Surrogate Measure of Medullary Oxygenation During Angiotensin II Therapy in Septic Acute Kidney Injury

  2018cites this paper
• A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock

  2018cites this paper
• R1 autonomic nervous system in acute kidney injury

  2017cites this paper
• Isolation of Intact Mitochondria from Skeletal Muscle by Differential Centrifugation for High-resolution Respirometry Measurements.

  2017cites this paper
• Optimal Cutoff Value for Lung Injury Prediction Score and Potential Confounders for Identifying the Risk of Developing Acute Respiratory Distress Syndrome.

  2017cites this paper
• The authors reply.

  2017cites this paper
• Bridging the Translational Gap: The Challenges of Novel Drug Development in Critical Care

  2017cites this paper
• Renin-Angiotensin-Aldosterone System Blockade Use in Sepsis Patients: Did It Impact Renal Outcomes?

  2017cites this paper
• Novel Therapies for Acute Kidney Injury

  2017influential citation
• Mitochondrial and endoplasmic reticulum dysfunction and related defense mechanisms in critical illness-induced multiple organ failure.

  2017cites this paper
• Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?

  2017cites this paper
• Angiotensin II in Refractory Septic Shock

  2017cites this paper
• The use of angiotensin II in distributive shock

  2016cites this paper
• Analgesia in clinically relevant rodent models of sepsis

  2016cites this paper
• Effects of cytokines on the expression of angiotensin II type 1 receptors in vascular smooth muscle cells

  2016cites this paper
• Septic porcine blood does not further activate coagulation during in vitro membrane oxygenation

  2016cites this paper
• Clonidine Restores Pressor Responsiveness to Phenylephrine and Angiotensin II in Ovine Sepsis*

  2015cites this paper
• Angiotensin II in septic shock

  2015cites this paper
• Research progress of measures for renal perfusion adjustment in sepsis patients

  2015cites this paper
• Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study

  2014cites this paper
• Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*.

  2014influential citation
• Mitochondrial function in sepsis

  2013cites this paper
• Kidney Novel Therapies for Acute Kidney Injury

  year unknowninfluential citation